Assay News and Research

RSS

KIPA shows promise in predicting chemotherapy response in triple negative breast cancer

Researchers at Baylor College of Medicine and collaborating institutions are developing a strategy to predict the response of triple negative breast cancer (TNBC) to chemotherapy, which would be a valuable tool for physicians deciding on the treatment with better probability of success on an individual basis.

21 Jul 2023

Understanding persistent COVID-19 symptoms: study explores early indicators of long COVID

Researchers investigated early biomarkers of post-acute sequelae of SARS-CoV-2 infection in individuals intensively sampled during the acute phase of COVID-19.

20 Jul 2023

Sense of smell may hold clues to Lewy body pathology: new evidence emerges

Researchers evaluated the impact of Lewy body (LB) positivity (+) on clinical outcomes such as cognition and smell among cognitively.

20 Jul 2023

Pro-inflammatory cytokine levels and their relation to preeclampsia severity

Researchers examine plasma interleukin-6, vascular cell adhesion molecule-1, and C-reactive protein levels in pregnant women with preeclampsia.

20 Jul 2023

Arrayjet announces collaboration with Chemspace to augment its small molecule microarray services for drug discovery

Arrayjet, a leading provider of inkjet liquid-handling solutions, today announced that it has partnered with Chemspace, the largest online catalogue of small molecules and biologics, to augment and streamline the Company’s small molecule microarray (SMM) service offering.

From Arrayjet Ltd 19 Jul 2023

Study reveals potential target for repairing beta-cell dysfunction in Type 2 diabetes

Researchers used a murine model to demonstrate that functional excision of murine PITPNA eventually led to hyperglycemia in mice.

19 Jul 2023

Eternal youth? Chemical cocktails prove effective in cell age reversal

Researchers identified chemical drug combinations that could reverse cellular aging.

19 Jul 2023

Merck awards 2023 Future Insight Prize for research into air sensor to detect pandemic pathogens

Merck KGaA, Darmstadt, Germany, awarded its 2023 Future Insight Prize to Khalid Salaita, professor of chemistry at Emory University. The award comes with $540,000 to fund the next phase of research into an air sensor that can continuously monitor indoor spaces for pathogens that can cause pandemics.

17 Jul 2023

Seroepidemiology study suggests EV-A71 vaccine effective in Guangzhou, China

Enterovirus A71 (EV-A71) is a significant hand-foot-mouth disease (HFMD) etiology. The inactivated EV-A71 vaccines were approved in China in 2016.

17 Jul 2023

Are antidrug antibodies reducing the effectiveness of rheumatoid arthritis treatment?

Researchers examined the association between antidrug antibodies and the response to treatments for rheumatoid arthritis.

17 Jul 2023

The prognostic value of PCSK9 levels for predicting major adverse cardiovascular events and mortality in diabetics

Researchers investigate the prognostic value of PCSK9 levels in diabetes patients to predict all-cause mortality and major adverse cardiovascular events.

17 Jul 2023

New proteomic insights: cerebrospinal fluid biomarkers show promise in detecting dementia with Lewy bodies

Researchers conducted cerebrospinal fluid (CSF) proteome profiling and identified CSF proteins.

17 Jul 2023

Boosted immunity: Delta and Omicron-BA.1 infections enhance protection in vaccinated patients

Researchers examined the immune response and potential cross-protection in hospitalized patients with breakthrough infections.

17 Jul 2023

Unveiling the key defender: PLSCR1 identified as a potent anti-SARS-CoV-2 factor in COVID-19 immunity

Researchers identified the anti-SARS-CoV-2 function of phospholipid scramblase 1 (PLSCR1).

14 Jul 2023

New study reveals mast cells' surprising role in allergy-related avoidance behavior

Researchers showed that mast cells and IgE are the key orchestrators of antigen-specific avoidance.

14 Jul 2023

Quanterix launches LucentAD Biomarker blood test to aid physician diagnosis of Alzheimer’s disease in patients

Quanterix Corporation, a company fueling scientific discovery and breakthrough diagnostics through ultrasensitive biomarker detection, today announced it has launched LucentAD, a test to assist in the evaluation of patients experiencing cognitive symptoms consistent with the early signs of Alzheimer’s disease (AD).

From Quanterix 14 Jul 2023

Assay News and Research

KIPA shows promise in predicting chemotherapy response in triple negative breast cancer

Understanding persistent COVID-19 symptoms: study explores early indicators of long COVID

Sense of smell may hold clues to Lewy body pathology: new evidence emerges

Pro-inflammatory cytokine levels and their relation to preeclampsia severity

Arrayjet announces collaboration with Chemspace to augment its small molecule microarray services for drug discovery

Study reveals potential target for repairing beta-cell dysfunction in Type 2 diabetes

Eternal youth? Chemical cocktails prove effective in cell age reversal

Merck awards 2023 Future Insight Prize for research into air sensor to detect pandemic pathogens

Seroepidemiology study suggests EV-A71 vaccine effective in Guangzhou, China

Are antidrug antibodies reducing the effectiveness of rheumatoid arthritis treatment?

The prognostic value of PCSK9 levels for predicting major adverse cardiovascular events and mortality in diabetics

New proteomic insights: cerebrospinal fluid biomarkers show promise in detecting dementia with Lewy bodies

Boosted immunity: Delta and Omicron-BA.1 infections enhance protection in vaccinated patients

Unveiling the key defender: PLSCR1 identified as a potent anti-SARS-CoV-2 factor in COVID-19 immunity

New study reveals mast cells' surprising role in allergy-related avoidance behavior

Quanterix launches LucentAD Biomarker blood test to aid physician diagnosis of Alzheimer’s disease in patients

Exploring the relationship between epigenetic aging and gut microbiome composition in physically fit men and women

Investigating the role of T-cell immunity in long COVID

IL-9 identified as contributor to viral spread and airway inflammation in COVID-19

Researchers develop a chemical approach to reverse aging

eBook: Using iPSCs models for human disease research and drug discovery eBook

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News